LivaNova (NASDAQ:LIVN) Cut to “Buy” at StockNews.com

StockNews.com lowered shares of LivaNova (NASDAQ:LIVN) from a strong-buy rating to a buy rating in a report issued on Saturday morning.

A number of other research firms have also commented on LIVN. Robert W. Baird boosted their price target on shares of LivaNova from $66.00 to $72.00 and gave the company an “outperform” rating in a research report on Thursday, October 31st. Mizuho reduced their target price on LivaNova from $80.00 to $70.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. Baird R W raised LivaNova from a “hold” rating to a “strong-buy” rating in a report on Tuesday, September 17th. Needham & Company LLC reiterated a “buy” rating and set a $75.00 price target on shares of LivaNova in a research report on Tuesday, November 12th. Finally, Stifel Nicolaus upped their price objective on shares of LivaNova from $70.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, July 25th. One investment analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $69.17.

LivaNova Trading Up 0.8 %

Shares of LIVN opened at $52.53 on Friday. The business’s 50-day moving average price is $51.77 and its 200-day moving average price is $52.86. The stock has a market cap of $2.85 billion, a PE ratio of 125.05 and a beta of 1.01. LivaNova has a twelve month low of $42.75 and a twelve month high of $64.47. The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46.

Institutional Trading of LivaNova

Hedge funds have recently bought and sold shares of the company. Fifth Third Bancorp raised its stake in shares of LivaNova by 97.1% during the second quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock worth $37,000 after acquiring an additional 332 shares in the last quarter. Hexagon Capital Partners LLC raised its position in LivaNova by 117.8% in the 2nd quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock worth $37,000 after purchasing an additional 370 shares during the period. Lazard Asset Management LLC bought a new stake in LivaNova in the first quarter worth $84,000. Canada Pension Plan Investment Board purchased a new stake in LivaNova during the second quarter valued at about $88,000. Finally, Acadian Asset Management LLC bought a new position in shares of LivaNova during the first quarter valued at about $94,000. Institutional investors own 97.64% of the company’s stock.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.